申请人:CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
公开号:US20220033376A1
公开(公告)日:2022-02-03
Provided is an indole compound. In particular, disclosed are a compound represented by formula (II) or an isomer or pharmaceutically acceptable salt thereof and a use of the same as an estrogen receptor antagonist in preparing a drug for treating estrogen receptor-positive breast cancer.